1.Development of a balloon sensor device for force-electrical coupling measurement of esophagus.
Peng RAN ; Ying ZHONG ; Yingbing LAI ; Lei LIU ; Yanhang ZHU ; Huantao ZHU
Journal of Biomedical Engineering 2025;42(3):610-619
To address the challenges of capturing micro-strains in detecting esophageal motility disorders and the limitations of existing high-resolution manometry and functional intraluminal imaging probes in directly measuring esophageal tissue electrical impedance, this study proposes a novel flexible balloon sensor structure that integrates a piezoelectric film assembly with a distributed impedance electrode array. Using the electrical analysis module in the finite element analysis (FEA) software, simulations of the forward problem for esophageal impedance detection were conducted to optimize the excitation source parameters, and a physical prototype was fabricated. Under a relative excitation mode with a voltage sensitivity of 2.059%, the voltage output characteristics of the impedance electrode array were analyzed during linear changes in the balloon filling volume. Based on the performance variation of the piezoelectric film assembly, 80% was selected as the optimal filling volume. Force-electric coupling tests were conducted on the balloon sensor using a pressure testing platform, revealing that both the piezoelectric film assembly inside the balloon and the impedance electrodes outside the balloon exhibited significant load differentiation characteristics as the force application point shifted. In summary, this balloon sensor facilitates the localization of force application while simultaneously analyzing esophageal tissue properties, offering a novel diagnostic approach and objective tool for esophageal disease detection.
Esophagus/physiology*
;
Electric Impedance
;
Humans
;
Finite Element Analysis
;
Manometry/methods*
;
Electrodes
;
Esophageal Motility Disorders/physiopathology*
;
Equipment Design
2.Metabolic and alcohol-associated liver disease: A novel liver disease entity
Yue FENG ; Hongqin XU ; Panshili HAN ; Tao LIU ; Yanhang GAO
Journal of Clinical Hepatology 2025;41(11):2235-2239
The term “metabolic and alcohol-related liver disease (MetALD)” recently proposed emphasizes the synergistic role of metabolic dysfunction and alcohol exposure in the progression of liver injury. Although this theoretical framework improves the understanding of the multifactorial and complex nature of liver disease, its clinical application still faces numerous new challenges in diagnosis and treatment. This article summarizes the latest evidence for the prevalence, potential pathogenesis, clinical diagnostic markers, and treatment of MetALD and particularly emphasizes the urgency to develop reliable preclinical models that can accurately simulate the intricate pathophysiology of this disease due to various factors. This article also provides a systematic evaluation of emerging therapies including fecal microbiota transplantation and nutritional interventions and proposes the future directions for drug innovation in MetALD.
3.Copper homeostasis dysregulation promoting cell damage and the association with liver diseases.
Tao LIU ; Yali LIU ; Feiyu ZHANG ; Yanhang GAO
Chinese Medical Journal 2023;136(14):1653-1662
Copper plays an important role in many metabolic activities in the human body. Copper level in the human body is in a state of dynamic equilibrium. Recent research on copper metabolism has revealed that copper dyshomeostasis can cause cell damage and induce or aggravate some diseases by affecting oxidative stress, proteasome, cuprotosis, and angiogenesis. The liver plays a central role in copper metabolism in the human body. Research conducted in recent years has unraveled the relationship between copper homeostasis and liver diseases. In this paper, we review the available evidence of the mechanism by which copper dyshomeostasis promotes cell damage and the development of liver diseases, and identify the future research priorities.
Humans
;
Copper/metabolism*
;
Homeostasis
;
Oxidative Stress
;
Liver Diseases
4.Effectiveness of increasing alcohol excise taxes in the management of alcohol-associated liver disease in China
Feiyu ZHANG ; Peng XIAO ; Yali LIU ; Tao LIU ; Yanhang GAO
Journal of Clinical Hepatology 2023;39(7):1703-1707
Increasing alcohol excise taxes has been confirmed by the World Health Organization as the most cost-effective public policy for reducing alcohol consumption at the population level. In recent years, studies in foreign countries have believed that increasing alcohol excise taxes can improve the burden of alcohol-associated liver disease (ALD), but it is still unclear whether this policy is applicable to ALD management in China. Therefore, with reference to related research evidence in China and globally, this article analyzes the key factors influencing the effectiveness of the policy of increasing alcohol excise taxes from the perspective of ALD management in China, including tax shifting, price elasticity of demand, and unrecorded alcohol, and introduces other public policies that help curb ALD. We think that increasing alcohol excise taxes is currently a useful but not effective policy for improving the burden of ALD in China.
5.Culture-Positive Spontaneous Ascitic Infection in Patients with Acute Decompensated Cirrhosis: Multidrug-Resistant Pathogens and Antibiotic Strategies
Jing LIU ; Yanhang GAO ; Xianbo WANG ; Zhiping QIAN ; Jinjun CHEN ; Yan HUANG ; Zhongji MENG ; Xiaobo LU ; Guohong DENG ; Feng LIU ; Zhiguo ZHANG ; Hai LI ; Xin ZHENG
Yonsei Medical Journal 2020;61(2):145-153
Alanine Transaminase
;
Amikacin
;
Anti-Bacterial Agents
;
Aztreonam
;
Bilirubin
;
Carbapenems
;
Ceftazidime
;
China
;
Creatinine
;
Cross Infection
;
Escherichia coli
;
Fibrosis
;
Fungi
;
Gram-Negative Bacteria
;
Gram-Positive Bacteria
;
Hemorrhage
;
Hospitals, Teaching
;
Humans
;
International Normalized Ratio
;
Klebsiella pneumoniae
;
Length of Stay
;
Leukocyte Count
;
Linezolid
;
Methicillin-Resistant Staphylococcus aureus
;
Mortality
;
Multivariate Analysis
;
Prevalence
;
Proportional Hazards Models
;
Retrospective Studies
;
Risk Factors
;
Vancomycin
6. Application of direct antiviral drugs in special patients with HCV infection
Chang JIANG ; Chunyan LIU ; Shuang SHAO ; Yanhang GAO
Chinese Journal of Hepatology 2018;26(4):316-320
Patients with HCV infection can develop decompensated cirrhosis, hepatocellular carcinoma (HCC), even liver failure. As a result, efficient antiviral treatment is very essential to prevent HCV-related disease progression. Newly developed direct-acting antiviral agents (DAAs) have shown safety profile, favorable tolerability, and relatively short duration, which provide an opportunity to expand the number of patients who can be treated for HCV infection. There is a need for further clinical observation and summaries for DAAs in a real world. In the era of DAAs, special patients with HCV infection still get lots of attention from doctors. This review aims at the application of DAAs in patients with HCV infection, combined with chronic kidney diseases, hepatocellular carcinoma, HBV/HCV co-infection, HIV/HCV co-infection, post liver transplantation, pregnancy, children, lymphoma and retreatment.
7. Glucocorticoids and liver diseases
Xiaowen LIU ; Peiyan LIU ; Chang JIANG ; Yanhang GAO
Chinese Journal of Hepatology 2018;26(7):557-560
Glucocorticoids is a type of steroid hormone secreted from zona fasciculata of adrenal cortex.As an immune and inflammatory inhibitor, glucocorticoids has been used to treat many kinds of diseases.T cell response plays a crucial role in the pathogenesis of liver diseases. However, the role of glucocorticoids in the mechanism and treatment of liver disease in current clinical practice is controversial. This paper summarizes the progress of glucocorticoid use for the treatment of liver diseases in recent years. References will be provided for how to grasp the indications,application timing and proper dosage of glucocorticoids in liver diseases.
8.Research advances in silybin in treatment of drug-induced liver injury
Shuang SHAO ; Chunyan LIU ; Yanhang GAO
Journal of Clinical Hepatology 2017;33(6):1179-1182
Drug-induced liver injury is commonly seen in ctinical practice and is usually caused by antipsychotic drags,antitubercnlar agents,paracetamol,and statins.Silybin,a substance with biological activity in silymarin extract,has antioxidant,anti-inflammatory,and anti-fibrosis effects.This article summarizes the research advances in silybin in the prevention and treatment of drug-induced liver injury.
9.Immunotherapy experimental study of γδT cells from human peripheral blood on human liver cell nude mouse xenograft in vivo
Li XIA ; Yanfei CHI ; Xiaofeng LI ; Juan WANG ; Bailin LIU ; Guihong HAN ; Yanhang LIU ; Yuxia LIU
Chinese Journal of Immunology 2017;33(5):702-706
Objective:To study the immunotherapy effects of different doses of human peripheral blood γδT cells on human hepatoma cells (SMMC-7721) xenograft model.Methods: (1)The nude mouse model of liver cancer was established by inoculated BALB/c mouse subcutaneous with human hepatoma cell line (SMMC-7721).(2)The mononuclear cells in healthy human were extracted from peripheral blood,and specific amplification γδT cells in vitro.(3) The nude mouse model divided into 5 groups by random.The positive control group was 5-Fu,negative control group was normal saline(NS).The treatment group was injected different doses of γδT cells(1×105,5×105 and 25×105)by nude mice tail vein.The positive control group injected 5-Fu by enterocoelia,negative control group injected NS by tail veins.The inhibition effect of different dose γδT cells on tumor was observed,including weight,food intake and growth conditions,etc.and the changes of tumor volume (TV),relative tumor volume (RTV)and relative tumor appreciation rate[T/C(%)] were compared with positive control group and negative control group.Results: Different dose of γδT cells had different degree of inhibition on nude mouse xenograft growth.RTV compared with saline negative control group was statistically significant (P<0.05).Compared with the positive control group of 5-Fu,the TV growth was significantly lower than the 5-Fu,degree of inhibition was similar in RTV each dose group,and all slightly higher than the 5-Fu positive control group.The each dose group of T/C (%)was slightly lower than the relative tumor proliferation rate of the control group of 5-Fu,but had no significant difference.Conclusion: The γδT cells from peripheral blood had significant inhibitory effect on nude mice transplanted liver tumor and it may be used as a new treatment for liver cancer immunotherapy provide experimental data.
10. Hepatitis C-related hepatocellular carcinoma and the treatment with direct-acting antiviral agents
Xu LIU ; Yanhang GAO ; Junqi NIU
Chinese Journal of Hepatology 2017;25(12):944-947
With the wide use of direct-acting antiviral agents (DAAs), more and more patients with chronic hepatitis C achieve sustained virological response; however, no consensus has been reached on the application of DAAs in the treatment of hepatitis C virus-related hepatocellular carcinoma (HCC). This article summarizes and evaluates related issues in this field, including whether antiviral therapy with DAAs in patients with hepatitis C can increase the incidence or recurrence rate of HCC, as well as whether DAAs can be used for hepatitis C in HCC patients after antitumor treatment and the efficacy of DAAs in such patients.

Result Analysis
Print
Save
E-mail